Benzothienopyrazinedione compounds and their preparation and use
US5182279A · kind A · utility
7Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 1991 |
| Grant date | Jan 26, 1993 |
| Priority date | — |
| Expiry date | Apr 18, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel [1]benzothieno[2,3-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof of the general formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen, halogen, alkyl, alkoxy or trifluoromethyl. The compounds are useful for treating a central nervous system ailment associated with the NMDA receptor-associated glycine site.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.